Testing effectiveness (Phase 2)WithdrawnNCT03989635
What this trial is testing
Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.
Who this might be right for
AsthmaAsthma, BronchialBronchial Asthma+2 more
Novartis Pharmaceuticals